Biomedical Engineering Reference
In-Depth Information
O
H
N
O
R
1
R
3
H
H
OCH
3
O
N
H
N
H
R
2
H
R
O
O
O
OH
O
O
R
1
R
2
Asc8 =
Asc12 =
Asc18 =
R
3
R
O
R
HO
O
N
H
NH
2
Peptide 1
Peptide 2
CH
2
CH
2
CH
2
CH
2
OH
CH
2
OH
O
OH
CH
2
OH
CH
2
OH
OH
CH
2
Peptide 3
CH
2
(4)
(1)
(2)
O
H
H
N
COOH
COOH
H
N
O
N
H
O
O
Cl
−
C
16
H
33
O
O
+
H
N
Cl
−
O
O
C
C
16
H
33
+
N
H
H
N
O
N
C
N
C
N
H
C
16
H
33
CH
2
CH
2
+
Cl
−
N
HN
HN
HN
Fmoc-Val-Asp-OH
(6)
O
O
Cl
−
Cl
−
O
O
N
+
+
N
C
N
H
O
N
N
H
C
16
H
33
N
C
C
16
H
33
O
CH
2
+
CH
2
+
CH
C
NH
C
16
H
33
CH
CNH
C
16
H
33
HN
Cl
−
Cl
−
CH
2
N
CH
2
(3)
HN
O
−
Na
+
(2)
(1)
R
1
O
O
O
N
O
C
15
H
31
HN
O
−
Na
+
R=
H
OH / Na
HN
CH
C
(3)
R
2
O
CH
2
O
R
(4)
HN
(5)
(7)
Scheme 5.4
Molecular structures of gelators in Table 5.1 that served as reducing and capping agents for gold and silver
nanoparticle synthesis.
Search WWH ::
Custom Search